A Dose-Ranging Study of AAV-hAADC Therapy in Parkinsonian Monkeys

The main medication for idiopathic Parkinson disease is l-Dopa. Drug efficacy declines steadily in part because the converting enzyme, aromatic l-amino acid decarboxylase (AADC), is lost concomitant with substantia nigra atrophy. Over the past decade, we have developed a gene therapy approach in whi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Forsayeth, John R., Eberling, Jamie L., Sanftner, Laura M., Zhen, Zhu, Pivirotto, Philip, Bringas, John, Cunningham, Janet, Bankiewicz, Krystof S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2006
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2725179/
https://ncbi.nlm.nih.gov/pubmed/16781894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2006.04.008
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia